|
|
DSpace at RU >
Browsing by Author Alffenaar, J.W.C.
Showing results 1 to 8 of 8
| Full Text | Issue Date | Title | Author(s) | | 2012 | Plasma concentrations of caspofungin at two different dosage regimens in a patient with hepatic dysfunction | van der Elst, K.C.; Bruggemann, R.J.M.; Rodgers, M.G.; Alffenaar, J.W.C. |
| 2011 | Fluoroquinolones, the cornerstone of treatment of drug-resistant tuberculosis: a pharmacokinetic and pharmacodynamic approach. | Pranger, A.D.; Alffenaar, J.W.C.; Aarnoutse, R.E. |
| 2011 | Evaluation of moxifloxacin for the treatment of tuberculosis: 3 years of experience | Pranger, A.D.; Altena, R. van; Aarnoutse, R.E.; Soolingen, D. van; Uges, D.R.A., et al |
| 2011 | Susceptibility of clinical Mycobacterium tuberculosis isolates to a potentially less toxic derivate of linezolid, PNU-100480. | Alffenaar, J.W.C.; Laan, T. van der; Simons, S.O.; Werf, T.S. van der; Kasteele, P.J. van de, et al |
| 2011 | Limited-sampling strategies for therapeutic drug monitoring of moxifloxacin in patients with tuberculosis | Pranger, A.D.; Kosterink, J.G.W.; Altena, R. van; Aarnoutse, R.E.; Werf, T.S. van der, et al |
| 2009 | Pharmacokinetics of moxifloxacin in cerebrospinal fluid and plasma in patients with tuberculous meningitis. | Alffenaar, J.W.C.; Altena, R. van; Bokkerink, H.J.; Luijckx, G.J.R.; Soolingen, D. van, et al |
| 2009 | Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents. | Bruggemann, R.J.M.; Alffenaar, J.W.C.; Blijlevens, N.M.A.; Billaud, E.M.; Kosterink, J.G.W., et al |
| 2008 | Pharmacokinetic drug interactions of azoles. | Bruggemann, R.J.M.; Alffenaar, J.W.C.; Blijlevens, N.M.A.; Billaud, E.M.; Kosterink, J.G.W., et al |
Showing results 1 to 8 of 8
|